Evidence map›Paper›PMID 40938333›Full record

ReviewCurrent rheumatology reports2025

What can Animal Models tell us About T Cells in Spondyloarthritis Pathogenesis?

Judith A Smith

Abstract readReview
In one paragraph

Review in Current rheumatology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Judith A SmithDepartment of Pediatrics, The University of Wisconsin-Madison, 1550 Linden Dr, Rm 4159, Madison, WI, 53709, USA. Jsmith27@wisc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewSpondyloarthritis animal models such as the HLA-B27 transgenic rat, SKG mouse and cytokine overexpression models have proven useful for testing hypotheses regarding pathogenesis. Recent developments in the field from human studies have shifted attention to HLA-B2705 restricted CD8+ T cell clonotype expansion and the "arthritogenic peptide" theory. Since human and rodent MHC and T cell compartments differ, translatability comes into question. In this review, we will discuss the advantages and caveats of several spondyloarthritis rodent models. We will review classic studies and more recent reports providing insight into pathologic T cells outside the canonical paradigm of MHC Class I-CD8+ T cell interaction. RECENT

findingsAnimal models have revealed requisite "ingredients' for a spondyloarthritis phenotype, including inflammatory mediators and lymphoid cell types. Most of these models highlight the role of Th17 cells and other IL-17 producing cells. Indeed, the IL-23 minicircle model directly led to the identification of IL-17 producing γδ T cells in typical spondyloarthritis anatomic locations. In addition to identifying lymphocyte players, animal models have elucidated T cell regulation, including innate immune (e.g. neutrophil) T cell crosstalk and gut-joint trafficking. Current studies are also beginning to clarify roles for innate lymphocytic cells such as MAIT and iNKT cells. Animal model studies have provided vital insight into T cell pathogenic mechanisms outside canonical MHC Class I-CD8 interaction. Many of these findings have been replicated in human subjects. Furthermore, work from animal models directly supported the development of IL17 and IL23 targeting therapeutics, attesting to their relevance. MAIN TEXT: (~ 4246 words), 1 Figure and 1 Table.

Indexed as

Disease Models, AnimalSpondylarthritisT-LymphocytesAnimalsHLA-B27 AntigenHumansMiceRatsHLA-B27 AntigenAnimal modelsIL-17Immune dysregulationSpondyloarthritisT cellsUPR

Identifiers

PMID40938333
PMCPMC12431933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.